Novartis AG
CHO CELL EXPRESSED HET IL-15
Last updated:
Abstract:
The present invention relates to IL-15/IL-15R.alpha. heterodimer produced in a CHO cell line, and method of producing the heterodimer and method of treatment using the heterodimer.
Status:
Application
Type:
Utility
Filling date:
29 Jan 2021
Issue date:
12 Aug 2021